Insight Molecular Diagnostics Inc.
IMDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,881 | $1,503 | $958 | $2,198 |
| % Growth | 25.1% | 56.9% | -56.4% | – |
| Cost of Goods Sold | $1,141 | $1,090 | $976 | $778 |
| Gross Profit | $740 | $413 | -$18 | $1,420 |
| % Margin | 39.3% | 27.5% | -1.9% | 64.6% |
| R&D Expenses | $9,839 | $9,294 | $7,301 | $5,035 |
| G&A Expenses | $13,144 | $12,978 | $21,516 | $20,387 |
| SG&A Expenses | $13,785 | $13,285 | $21,533 | $20,392 |
| Sales & Mktg Exp. | $641 | $307 | $17 | $5 |
| Other Operating Expenses | $38,157 | $2,970 | -$10,855 | $29,718 |
| Operating Expenses | $61,781 | $25,549 | $17,979 | $55,145 |
| Operating Income | -$61,041 | -$25,136 | -$17,997 | -$53,725 |
| % Margin | -3,245.1% | -1,672.4% | -1,878.6% | -2,444.3% |
| Other Income/Exp. Net | $378 | $281 | -$615 | $854 |
| Pre-Tax Income | -$60,663 | -$24,855 | -$18,612 | -$52,871 |
| Tax Expense | $0 | $0 | $0 | -$9,261 |
| Net Income | -$60,663 | -$27,781 | -$72,902 | -$64,097 |
| % Margin | -3,225% | -1,848.4% | -7,609.8% | -2,916.2% |
| EPS | -4.661 | -3.75 | -20 | -14.4 |
| % Growth | -24.3% | 81.3% | -38.9% | – |
| EPS Diluted | -4.661 | -3.75 | -20 | -14.4 |
| Weighted Avg Shares Out | 13,071 | 7,651 | 5,540 | 4,446 |
| Weighted Avg Shares Out Dil | 13,071 | 7,651 | 5,540 | 4,446 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $84 | $52 | $83 | $209 |
| Depreciation & Amortization | $1,564 | $1,680 | $5,220 | $4,205 |
| EBITDA | -$59,015 | -$23,123 | -$13,309 | -$48,457 |
| % Margin | -3,137.4% | -1,538.5% | -1,389.2% | -2,204.6% |